Cargando…
Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care
BACKGROUND: Screening of primary care patients at risk for left ventricular systolic dysfunction by a simple blood-test might reduce referral rates for echocardiography. Whether or not natriuretic peptide testing is a useful and cost-effective diagnostic instrument in primary care settings, however,...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267193/ https://www.ncbi.nlm.nih.gov/pubmed/18298821 http://dx.doi.org/10.1186/1471-2296-9-14 |
_version_ | 1782151621486051328 |
---|---|
author | Koschack, Janka Scherer, Martin Lüers, Claus Kochen, Michael M Wetzel, Dirk Kleta, Sibylle Pouwels, Claudia Wachter, Rolf Herrmann-Lingen, Christoph Pieske, Burkert Binder, Lutz |
author_facet | Koschack, Janka Scherer, Martin Lüers, Claus Kochen, Michael M Wetzel, Dirk Kleta, Sibylle Pouwels, Claudia Wachter, Rolf Herrmann-Lingen, Christoph Pieske, Burkert Binder, Lutz |
author_sort | Koschack, Janka |
collection | PubMed |
description | BACKGROUND: Screening of primary care patients at risk for left ventricular systolic dysfunction by a simple blood-test might reduce referral rates for echocardiography. Whether or not natriuretic peptide testing is a useful and cost-effective diagnostic instrument in primary care settings, however, is still a matter of debate. METHODS: N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, clinical information, and echocardiographic data of left ventricular systolic function were collected in 542 family practice patients with at least one cardiovascular risk factor. We determined the diagnostic power of the NT-proBNP assessment in ruling out left ventricular systolic dysfunction and compared it to a risk score derived from a logistic regression model of easily acquired clinical information. RESULTS: 23 of 542 patients showed left ventricular systolic dysfunction. Both NT-proBNP and the clinical risk score consisting of dyspnea at exertion and ankle swelling, coronary artery disease and diuretic treatment showed excellent diagnostic power for ruling out left ventricular systolic dysfunction. AUC of NT-proBNP was 0.83 (95% CI, 0.75 to 0.92) with a sensitivity of 0.91 (95% CI, 0.71 to 0.98) and a specificity of 0.46 (95% CI, 0.41 to 0.50). AUC of the clinical risk score was 0.85 (95% CI, 0.79 to 0.91) with a sensitivity of 0.91 (95% CI, 0.71 to 0.98) and a specificity of 0.64 (95% CI, 0.59 to 0.67). 148 misclassifications using NT-proBNP and 55 using the clinical risk score revealed a significant difference (McNemar test; p < 0.001) that was based on the higher specificity of the clinical risk score. CONCLUSION: The evaluation of clinical information is at least as effective as NT-proBNP testing in ruling out left ventricular systolic dysfunction in family practice patients at risk. If these results are confirmed in larger cohorts and in different samples, family physicians should be encouraged to rely on the diagnostic power of the clinical information from their patients. |
format | Text |
id | pubmed-2267193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22671932008-03-13 Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care Koschack, Janka Scherer, Martin Lüers, Claus Kochen, Michael M Wetzel, Dirk Kleta, Sibylle Pouwels, Claudia Wachter, Rolf Herrmann-Lingen, Christoph Pieske, Burkert Binder, Lutz BMC Fam Pract Research Article BACKGROUND: Screening of primary care patients at risk for left ventricular systolic dysfunction by a simple blood-test might reduce referral rates for echocardiography. Whether or not natriuretic peptide testing is a useful and cost-effective diagnostic instrument in primary care settings, however, is still a matter of debate. METHODS: N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, clinical information, and echocardiographic data of left ventricular systolic function were collected in 542 family practice patients with at least one cardiovascular risk factor. We determined the diagnostic power of the NT-proBNP assessment in ruling out left ventricular systolic dysfunction and compared it to a risk score derived from a logistic regression model of easily acquired clinical information. RESULTS: 23 of 542 patients showed left ventricular systolic dysfunction. Both NT-proBNP and the clinical risk score consisting of dyspnea at exertion and ankle swelling, coronary artery disease and diuretic treatment showed excellent diagnostic power for ruling out left ventricular systolic dysfunction. AUC of NT-proBNP was 0.83 (95% CI, 0.75 to 0.92) with a sensitivity of 0.91 (95% CI, 0.71 to 0.98) and a specificity of 0.46 (95% CI, 0.41 to 0.50). AUC of the clinical risk score was 0.85 (95% CI, 0.79 to 0.91) with a sensitivity of 0.91 (95% CI, 0.71 to 0.98) and a specificity of 0.64 (95% CI, 0.59 to 0.67). 148 misclassifications using NT-proBNP and 55 using the clinical risk score revealed a significant difference (McNemar test; p < 0.001) that was based on the higher specificity of the clinical risk score. CONCLUSION: The evaluation of clinical information is at least as effective as NT-proBNP testing in ruling out left ventricular systolic dysfunction in family practice patients at risk. If these results are confirmed in larger cohorts and in different samples, family physicians should be encouraged to rely on the diagnostic power of the clinical information from their patients. BioMed Central 2008-02-25 /pmc/articles/PMC2267193/ /pubmed/18298821 http://dx.doi.org/10.1186/1471-2296-9-14 Text en Copyright © 2008 Koschack et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Koschack, Janka Scherer, Martin Lüers, Claus Kochen, Michael M Wetzel, Dirk Kleta, Sibylle Pouwels, Claudia Wachter, Rolf Herrmann-Lingen, Christoph Pieske, Burkert Binder, Lutz Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care |
title | Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care |
title_full | Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care |
title_fullStr | Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care |
title_full_unstemmed | Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care |
title_short | Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care |
title_sort | natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267193/ https://www.ncbi.nlm.nih.gov/pubmed/18298821 http://dx.doi.org/10.1186/1471-2296-9-14 |
work_keys_str_mv | AT koschackjanka natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT scherermartin natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT luersclaus natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT kochenmichaelm natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT wetzeldirk natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT kletasibylle natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT pouwelsclaudia natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT wachterrolf natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT herrmannlingenchristoph natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT pieskeburkert natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare AT binderlutz natriureticpeptidevsclinicalinformationfordiagnosisofleftventricularsystolicdysfunctioninprimarycare |